Vera Therapeutics Inc
NASDAQ:VERA
Cash Flow Statement
Cash Flow Statement
Vera Therapeutics Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(53)
|
(56)
|
(55)
|
(59)
|
(33)
|
(45)
|
(56)
|
(73)
|
(89)
|
(102)
|
(107)
|
(103)
|
(96)
|
(94)
|
(108)
|
(134)
|
(152)
|
(175)
|
(218)
|
(252)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
2
|
3
|
4
|
6
|
7
|
9
|
10
|
11
|
11
|
11
|
13
|
15
|
18
|
21
|
24
|
29
|
33
|
|
| Other Non-Cash Items |
18
|
18
|
16
|
15
|
5
|
8
|
13
|
18
|
15
|
15
|
15
|
10
|
10
|
10
|
11
|
12
|
15
|
18
|
24
|
29
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
2
|
3
|
3
|
2
|
5
|
6
|
7
|
7
|
7
|
7
|
|
| Change in Working Capital |
0
|
1
|
(2)
|
(1)
|
4
|
9
|
4
|
3
|
7
|
2
|
9
|
5
|
(6)
|
(16)
|
(9)
|
1
|
3
|
2
|
9
|
12
|
|
| Cash from Operating Activities |
(35)
N/A
|
(37)
-5%
|
(42)
-14%
|
(45)
-7%
|
(24)
+47%
|
(29)
-20%
|
(40)
-40%
|
(53)
-32%
|
(68)
-28%
|
(85)
-26%
|
(84)
+1%
|
(88)
-5%
|
(92)
-5%
|
(100)
-8%
|
(107)
-7%
|
(121)
-13%
|
(135)
-12%
|
(155)
-15%
|
(185)
-19%
|
(210)
-14%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
0
|
0
|
(5)
|
(5)
|
(5)
|
(5)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
1
|
1
|
1
|
(39)
|
(82)
|
(84)
|
(70)
|
(19)
|
(63)
|
(45)
|
(39)
|
(271)
|
(207)
|
(185)
|
(424)
|
(189)
|
(138)
|
(107)
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
1
+8 500%
|
1
N/A
|
(4)
N/A
|
(44)
-940%
|
(87)
-98%
|
(89)
-3%
|
(71)
+21%
|
(19)
+73%
|
(63)
-235%
|
(45)
+30%
|
(39)
+11%
|
(271)
-587%
|
(207)
+24%
|
(185)
+11%
|
(425)
-130%
|
(190)
+55%
|
(139)
+27%
|
(108)
+23%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
86
|
81
|
132
|
132
|
52
|
138
|
86
|
87
|
88
|
117
|
117
|
117
|
116
|
295
|
298
|
299
|
646
|
353
|
350
|
350
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
5
|
5
|
0
|
0
|
20
|
0
|
0
|
0
|
25
|
0
|
0
|
0
|
0
|
0
|
23
|
23
|
|
| Other |
(0)
|
(1)
|
(3)
|
(3)
|
(3)
|
(9)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(18)
|
(18)
|
(18)
|
(39)
|
(21)
|
(25)
|
(25)
|
|
| Cash from Financing Activities |
85
N/A
|
80
-6%
|
129
+60%
|
129
+0%
|
54
-58%
|
134
+149%
|
85
-36%
|
86
+1%
|
102
+18%
|
130
+27%
|
130
+0%
|
129
0%
|
134
+3%
|
302
+126%
|
305
+1%
|
306
+0%
|
607
+99%
|
332
-45%
|
349
+5%
|
349
+0%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
50
N/A
|
44
-13%
|
88
+101%
|
85
-3%
|
26
-69%
|
62
+139%
|
(41)
N/A
|
(56)
-35%
|
(36)
+35%
|
26
N/A
|
(17)
N/A
|
(3)
+80%
|
2
N/A
|
(69)
N/A
|
(9)
+87%
|
(0)
+98%
|
47
N/A
|
(14)
N/A
|
24
N/A
|
31
+27%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(35)
N/A
|
(37)
-5%
|
(42)
-13%
|
(45)
-7%
|
(29)
+36%
|
(34)
-17%
|
(45)
-34%
|
(58)
-29%
|
(68)
-17%
|
(85)
-26%
|
(84)
+1%
|
(88)
-5%
|
(92)
-5%
|
(100)
-8%
|
(107)
-7%
|
(121)
-13%
|
(136)
-12%
|
(156)
-15%
|
(187)
-19%
|
(211)
-13%
|
|